Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of more than 140 nationalities work at Novartis around the world.

In the UK, we employ approximately 1,300 people to serve healthcare needs across the whole of the UK, as well as supporting the global operations of Novartis. Since 2014, Novartis has invested over £200 million in R&D and is the single largest industry sponsor of clinical trials in the UK.

 

Website
Health PolicyNovember 25, 2020
Genomics: The roadmap to brighter futures
Speaking at the Public Policy Projects’ (PPP) Annual Conference 2020, a panel of experts discuss how the UK has situated itself as a global leader in genomic research, and the importance that this continues despite the challenges of Covid-19

Become a Partner

If you would like to enquire about working with Public Policy Projects, please contact partnerships@publicpolicyprojects.com for more information.
Public Policy Projects
  • operations@publicpolicyprojects.com
  • 0207 8399305

ISSN Number: 2517-2662